Search results for "Cardiac"

showing 10 items of 1495 documents

Segmental dyskinesia in Wolff–Parkinson–White syndrome: A possible cause of dilatative cardiomyopathy

2006

Wolff-Parkinson-White (WPW) is a syndrome characterized by the presence of an accessory pathway that skipping A-V node may lead the electrical stimulus from the atrium directly to the ventricle. Some studies reported the finding of myocardial dyskinesia in the segments precociously activated by the accessory pathway, at echocardiogram and at nuclear cardiac study. Soria et al. reported, in 1985, an increased incidence of dilative cardiomyopathy in patients with WPW. The pathophysiological pathway that leads to ventricular dilation may be due to the increase of end-diastolic pressure secondary to a tachycardia-induced cardiomyopathy. Tachycardia-induced cardiomyopathy is usually secondary to…

Cardiomyopathy DilatedTachycardiamedicine.medical_specialtyCardiomyopathyHemodynamicsAccessory pathwayAneurysmInternal medicinemedicineHumanscardiovascular diseasesChildbusiness.industryInfantArrhythmias Cardiacmedicine.diseasePathophysiologymedicine.anatomical_structureDyskinesiaVentriclecardiovascular systemCardiologyWolff-Parkinson-White Syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Differential responses to docosahexaenoic acid in primary and immortalized cardiac cells

2013

Abstract The importance of dietary polyunsaturated fatty acids (PUFAs) in the reduction of cardiovascular disease has been recognized for many years. Docosahexaenoic acid (22:6n3, DHA) is an n-3 PUFA known to affect numerous biological functions and provide cardioprotection; however, the exact molecular and cellular protective mechanism(s) remain unknown. In contrast, DHA also possesses many anti-tumorgenic properties including suppressing cell growth and inducing apoptosis. In the present study, we investigated the effect of DHA toward H9c2 cells (an immortalized cardiac cell line) and neonatal primary cardiomyocytes (NCM). Cells were treated with 0 μM, 10 μM or 100 μM DHA for upto 48 h. C…

CardioprotectionDocosahexaenoic AcidsbiologyCaspase 3Cell SurvivalInterleukin-6Cell growthCytochrome cBlotting WesternCytochromes cGeneral MedicineMitochondrionToxicologyMitochondria HeartCell LineRatsCell biologyDocosahexaenoic acidApoptosiscardiovascular systembiology.proteinAnimalsMyocytes CardiacViability assayCaspaseToxicology Letters
researchProduct

Heart Failure and Left Ventricular Dysfunction

2018

Heart failure (HF) and left ventricular (LV) dysfunction are the most concerning and serious cardiovascular complications of cancer therapies and cause an increase in morbidity and mortality. Some cancer treatments induce left ventricular dysfunction that appears early after exposure and therefore may adversely affect oncological therapy, while others generate cardiac injuries resulting in clinical problems only years later.

Cardioprotectionmedicine.medical_specialtyCardiotoxicitybusiness.industryInternal medicineHeart failuremedicineCardiologyCancerCardiac magnetic resonancemedicine.diseasebusiness
researchProduct

Cardioprotective effects of phytopigments via multiple signaling pathways.

2021

Abstract Background Cardiovascular diseases (CVDs) are among the deadliest non-communicable diseases, and millions of dollars are spent every year to combat CVDs. Unfortunately, the multifactorial etiology of CVDs complicates the development of efficient therapeutics. Interestingly, phytopigments show significant pleiotropic cardioprotective effects both in vitro and in vivo. Purpose This review gives an overview of the cardioprotective effects of phytopigments based on in vitro and in vivo studies as well as clinical trials. Methods A literature-based survey was performed to collect the available data on cardioprotective activities of phytopigments via electronic search engines such as Pub…

Cardiotonic AgentsPharmaceutical ScienceAnthraquinonesXanthophyllsBioinformaticsstatAntioxidantsAnthocyaninsDrug DiscoveryMedicineAnimalsHumansClinical efficacyProtein kinase BPharmacologyFlavonoidsbusiness.industryNF-kappa BAMPKCarotenoidsClinical trialComplementary and alternative medicineCardiotoxicitiesCardiac hypertrophyMolecular MedicineSignal transductionbusinessSignal TransductionPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Role of segmental and whole body bioelectrical impedance analysis in acute heart failure diagnosis.

2007

Cardiovascular System & Cardiology Cardiac & Cardiovascular Systems
researchProduct

Baseline adherence to the Mediterranean diet and major cardiovascular events: Prevención con dieta mediterránea trial

2014

Lifestyle modification, particularly dietary changes, is the cornerstone of population-based strategies for cardiovascular disease (CVD) prevention.1 Recently the Prevención con Dieta Mediterránea (PREDIMED) study,2 a 5-year randomized primary prevention trial (isrctn.org Identifier: ISRCTN35739639), showed a 30% reduction in incident CVD with Mediterranean diet (MeDiet) intervention in comparison with a control diet. At quarterly visits throughout the study, a validated 14-item MeDiet screening tool (Table 1) was used to assess conformity with this dietary pattern.3 Close monitoring of adherence to dietary instructions for CVD prevention is difficult in the clinical setting. Short dietary …

Cardiovascular eventAdultMalemedicine.medical_specialtyMediterranean dietTreatment outcomeMyocardial InfarctionDiet Mediterraneanlaw.inventionMedicina preventivaMediterranean cookingRandomized controlled triallawInternal medicineVegetablesCuina mediterràniaInternal MedicinemedicineHumansNutsDeath sudden cardiacPatient complianceDiet Fat-RestrictedDieta mediterraneaAgedProportional Hazards ModelsPreventive medicinebusiness.industryMalalties cardiovascularsFollow up studiesMiddle AgedPrimary PreventionStrokeDeath Sudden CardiacTreatment OutcomeCardiovascular diseasesCardiovascular DiseasesSpainPatient ComplianceFemale2168-6106businessFollow-Up Studies
researchProduct

The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study

2020

Abstract Background High blood lipid levels are known risk factors for atherosclerotic cardiovascular events, but associations between lipid levels and atrial fibrillation (AF) are unclear. Some previous studies have suggested an inverse association between lipid levels and AF referred to as the “cholesterol paradox”. Purpose To examine the prevalence of AF by differing lipid levels in a large population-based study of almost 14,000 adults in Poland. Methods The LIPIDOGRAM 2015 study is a cross-sectional study of adults aged 18 years and older recruited in Poland in 2015/2016 by 438 family physicians. Poisson regression models with robust variance were used to estimate prevalence ratios (PR…

Cardiovascular eventmedicine.medical_specialtyCholesterolbusiness.industryCardiac arrhythmiaAtrial fibrillationLipid Measurementmedicine.diseaseDrug usagechemistry.chemical_compoundWaist–hip ratiochemistryInternal medicineCardiologymedicineLDL Cholesterol Lipoproteinslipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Langzeitverlauf über 10 Jahre nach Ballondilatation bei stabiler und instabiler Angina pectoris

2008

OBJECTIVE To assess the cardiac status of patients ten years after percutaneous transluminal coronary artery angioplasty (PTCA). PATIENTS AND METHODS Data of 534 patients (436 men, 98 women; mean age 53.2 +/- 8 years) in whom a PTCA had been performed between 1983 and 1986 were analysed, based on a questionnaire answered 121 +/- 11 months after the initial procedure. At the time of PTCA 184 patients (35%) had unstable angina, 350 (65%) stable angina. RESULTS 116 patients (63%) with unstable angina and 164 (47%) with stable angina had at least one cardiac event after the initial PTCA (repeat PTCA, bypass operation, myocardial infarction, death). None of these events occurred in 68 patients (…

Cardiovascular eventmedicine.medical_specialtyPercutaneousbusiness.industryUnstable anginaGeneral Medicinemedicine.diseasesurgical procedures operativeBypass operationInternal medicineCardiologyMedicineCoronary artery angioplastyIn patientcardiovascular diseasesMyocardial infarctionbusinessCardiac statusDMW - Deutsche Medizinische Wochenschrift
researchProduct

Pressure–volume relationship by pharmacological stress cardiovascular magnetic resonance

2021

Abstract Background. The variation between rest and peak stress end-systolic pressure-volume relation (ΔESPVR) is an index of myocardial contractility, easily obtained during routine stress echocardiography and never tested during dipyridamole stress-cardiac magnetic resonance (CMR). We assessed the ΔESPVR index in patients with known/suspected coronary artery disease (CAD) who underwent dipyridamole stress-CMR.Methods. One-hundred consecutive patients (24 females, 63.76±10.17 years) were considered. ESPVR index was evaluated at rest and stress from raw measurement of systolic arterial pressure and end-systolic volume by biplane Simpson’s method. Results. The ΔESPVR index showed a good inte…

Cardiovascular magnetic resonance imagingReproducibilitymedicine.medical_specialtyCardiovascular magnetic resonance imaging; Dipyridamole; End-systolic pressure–volume relation; Myocardial contractilityEjection fractionmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingDipyridamolemedicine.diseaseDipyridamoleContractilityCoronary artery diseaseEnd-systolic pressure–volume relationInternal medicineCardiologyStress EchocardiographyMedicineRadiology Nuclear Medicine and imagingMyocardial contractilityCardiology and Cardiovascular MedicinebusinessCardiac imagingmedicine.drug
researchProduct

From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview

2019

Significance: Antineoplastic therapies have significantly improved the prognosis of oncology patients. However, these treatments can bring to a higher incidence of side-effects, including the worrying cardiovascular toxicity (CTX). Recent Advances: Substantial evidence indicates multiple mechanisms of CTX, with redox mechanisms playing a key role. Recent data singled out mitochondria as key targets for antineoplastic drug-induced CTX; understanding the underlying mechanisms is, therefore, crucial for effective cardioprotection, without compromising the efficacy of anti-cancer treatments. Critical Issues: CTX can occur within a few days or many years after treatment. Type I CTX is associated…

Cardiovascular toxicityPhysiologymedicine.medical_treatmentAntineoplastic drugClinical BiochemistryAntineoplastic Agents030204 cardiovascular system & hematologyPharmacologyBiochemistryCardiac cellcancer immunotherapy; chemotherapy; ErbB2 inhibitors; oxidative/nitrosative stress; tyrosine kinase inhibitors; vascular endothelial growth factor; Antineoplastic Agents; Cardiotoxicity; Humans; Mitochondria; Oxidation-Reduction03 medical and health scienceschemistry.chemical_compoundErbB2 inhibitors cancer immunotherapy chemotherapy oxidative/nitrosative stress tyrosine kinase inhibitors vascular endothelial growth factor0302 clinical medicinetyrosine kinase inhibitorcancer immunotherapy; chemotherapy; ErbB2 inhibitors; oxidative/nitrosative stress; tyrosine kinase inhibitors; vascular endothelial growth factorChemotherapy; ErbB2 inhibitors; vascular endothelial growth factor; tyrosine kinase inhibitors; oxidative/nitrosative stress; cancer immunotherapyCancer immunotherapytyrosine kinase inhibitorsmedicineHumansChemotherapyMolecular BiologyGeneral Environmental ScienceCardioprotectionComprehensive Invited ReviewsChemotherapyErbB2 inhibitorcancer immunotherapyvascular endothelial growth factorbusiness.industryCell BiologyCardiotoxicityMitochondriaVascular endothelial growth factoroxidative/nitrosative streErbB2 inhibitorschemistry030220 oncology & carcinogenesisGeneral Earth and Planetary SciencesbusinessOxidation-ReductionAfter treatmentoxidative/nitrosative stress
researchProduct